119th Congress
S. 3134
Combating Counterfeit Pharmaceuticals Act of 2025
- Introduced
- In committee
- Passed Senate
- Passed House
- To President
- Became law
- Sponsor
- Tom Cotton(R-AR)
- Introduced
- Nov 6, 2025
- Policy area
- International Affairs
- Committees
- Senate Committee on Banking, Housing, and Urban Affairs
- Official text
- Introduced in Senate · Congress.gov page
Cosponsors (1)
Original cosponsors (1)
- Pete Ricketts (R-NE)
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: A bill to amend the Fentanyl Sanctions Act to address trafficking of copy-cat and counterfeit drugs and active pharmaceutical ingredients, and for other purposes.
Latest action(Nov 6, 2025): Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Roll-call votes
No recorded votes on this bill.
Actions
- Nov 6, 2025 · Senate
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs. - Nov 6, 2025
Introduced in Senate